{"sourcedb":"DevicePMAs@therightstef","sourceid":"P990009_S014","text":"Approval for an alternate trade name for the approved kit configuration that does not contain a thrombin component.  The device, as modified, will be marketed under the trade name floseal nt hemostatic matrix and is indicated for use in surgical procedures (other than in ophthalmic) as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical.","project":"consensus_PMA_Age_Indications"}